|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2005-10-26
|
|
pubmed:abstractText |
To assess the efficacy and safety of a once-daily regimen with didanosine, lamivudine, saquinavir, and low-dose ritonavir in antiretroviral (ARV)-naive patients with tuberculosis treated with rifampin and the influence of rifampin on plasma trough concentration (Ctrough) of saquinavir.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1525-4135
|
|
pubmed:author |
pubmed-author:AzuajeCarlosC,
pubmed-author:DomingoPereP,
pubmed-author:FalcoVicençV,
pubmed-author:GatellJosep MJM,
pubmed-author:Lopez-ColomesJosep LluisJL,
pubmed-author:LopezRosa MRM,
pubmed-author:MallolasJosepJ,
pubmed-author:OcañaImmaI,
pubmed-author:PahissaAlbertA,
pubmed-author:PouLeonorL,
pubmed-author:RiberaEstebanE,
pubmed-author:SánchezPaquitaP,
pubmed-author:SambeaMaria AntoniaMA,
pubmed-author:SorianoAlexA
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
40
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
317-23
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:16249706-Adult,
pubmed-meshheading:16249706-Anti-HIV Agents,
pubmed-meshheading:16249706-Antitubercular Agents,
pubmed-meshheading:16249706-Didanosine,
pubmed-meshheading:16249706-Drug Administration Schedule,
pubmed-meshheading:16249706-Drug Therapy, Combination,
pubmed-meshheading:16249706-Drug-Induced Liver Injury,
pubmed-meshheading:16249706-Female,
pubmed-meshheading:16249706-Follow-Up Studies,
pubmed-meshheading:16249706-HIV Infections,
pubmed-meshheading:16249706-HIV Protease Inhibitors,
pubmed-meshheading:16249706-Humans,
pubmed-meshheading:16249706-Lamivudine,
pubmed-meshheading:16249706-Male,
pubmed-meshheading:16249706-Pilot Projects,
pubmed-meshheading:16249706-Ritonavir,
pubmed-meshheading:16249706-Saquinavir,
pubmed-meshheading:16249706-Spain,
pubmed-meshheading:16249706-Treatment Outcome,
pubmed-meshheading:16249706-Tuberculosis
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study).
|
|
pubmed:affiliation |
Infectious Diseases Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain. eribera@vhebron.net
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
